According to Sun Pharma, Palbociclib is approved by the US Food and Drugs Administration (FDA), European Medicines Agency (EMA) and Central Drugs Standard Control Organisation (CDSCO) in combination with hormonal therapies for patients with hormone receptor-positive, human epidermal growth f
In the past decade, researchers have started appreciating the importance of two-way communication that occurs between microbes in the gastrointestinal tract and the brain, known as the gut-brain axis.
Geneva [Switzerland], January 11 (ANI/PRNewswire): SELUTION SLR™, MedAlliance's novel sirolimus-eluting balloon, has received conditional FDA Investigational Device Exemption (IDE) approval to initiate its pivotal clinical trial for the treatment of coronary de novo lesions.
With the acquisition of Novelic, Sona Comstar said it has started building its third-business vertical of ADAS sensors and software to address the megatrends of increasing vehicle autonomy and automation.
A study published in the journal 'Science Advances' has revealed a novel cold domesticated repair mechanism for DNA damage in rice, as well as corresponding elite modules for the improvement of the chilling tolerance trait in rice with codon repeats at a single site.
New Delhi [India], January 6 (ANI/NewsVoir): Bestselling author L.A. Nolan unveiled his highly anticipated new book, "A Crate of Rags & Bones". Master of creating suspense and captivating readers, Nolan had received international acclaim for his previous book "Blood and Brown Sugar" by s
A study of kidney organoids in a novel lab environment might have downstream implications for the treatment of polycystic kidney disease (PKD), an incurable condition that affects more than 12 million people worldwide.
Researchers have uncovered novel candidate drug targets for non-alcoholic fatty liver disease (NAFLD) by using the latest technologies, including both single-nuclear sequencing of mice and human liver tissue and advanced 3D glass imaging of mice to characterize key scar-producing liver cells
Researchers at UCSF have developed a novel, potentially life-saving approach that may prevent antibodies from triggering immune rejection of engineered therapeutic and transplant cells.
According to McGill University research, different forms of brain injury produced by a concussion may cause identical symptoms in youngsters. A novel approach to investigating concussions could aid in the development of future medicines.